Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitegensight-biologic...
CategoryBioTech
Phone33-1-76-21-47-30
Employees
Founded2011
DescriptionBiopharmaceutical company

Offices

People

Board of Directors

Funding

TOTAL $41.7M
FUNDING TOTAL $41.7M
Series A, 4/2013
Novartis Venture Fund
Abingworth
Versant Ventures
Index Ventures
€32M

Tags

GenSight Biologics

Paris-based GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy based treatments of retinal degenerative diseases.

Based on recent results obtained by the teams of its scientific founders, the company develops innovative approaches to (i) prevent retinal degeneration in selected pathological conditions and (ii) to restore vision in patients suffering from very low vision or blindness.

Recent Milestones

Videos

Screenshots

GenSight Biologics screenshot
Above: GenSight Biologics
Uploaded: 4/10/13

Sources

  1. GenSight Biologics Raises €32m in a Series A Financing for Ophthalmic Gene Therapy (finance.yahoo.com) [edit]
Edit This Page
Last Edited 3/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy